Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel B-raf inhibitor as a potential treatment for BRAF mutant cancers

Nov. 8, 2013

Aposense PET radiotracer may identify high-risk atherosclerotic plaques

Nov. 8, 2013

GE Healthcare tests novel PET tracers for evaluating traumatic brain injury

Nov. 7, 2013

Inducers of immune tolerance increased in cystic fibrosis airway neutrophils

Nov. 7, 2013

AB Pharma and Zannan SciTech identify novel HCV NS5A inhibitors

Nov. 7, 2013

Biomarker predicts exacerbations in cystic fibrosis patients

Nov. 7, 2013

Tricyclo-DNA oligonucleotides show promise for SMA and DMD

Nov. 7, 2013

RNA-based adjuvant demonstrates potent boosting in vivo

Nov. 6, 2013

siRNA therapeutics targeted for AIP

Nov. 6, 2013

3pRNA RIG-I agonist displays activity against melanoma

Nov. 6, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...